中国中药(00570)今日盘中大跌6.84%,引发市场广泛关注。对此跌势的主要原因主要有以下两个方面:
首先,中国中药此前筹划被国药集团私有化,但由于预计无法在2024年10月18日前获得所需的境外直接投资批准,私有化进程受阻,公司最终宣布私有化建议告吹。这一消息无疑给投资者带来巨大失望和担忧,加剧了股价的跌势。
其次,资金面亦令中国中药股价承压。数据显示,南向资金近期连续5个交易日净卖出该股,仅在17日即净卖出312.6万股。大量资金流出加剧了对中国中药的抛售力道,是股价急跌的另一重要推手。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.